MedPath

Efficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative Colitis

Phase 2
Terminated
Conditions
Ulcerative Colitis
Interventions
Other: Placebo
Registration Number
NCT01659138
Lead Sponsor
Sanofi
Brief Summary

Primary Objective:

To assess the efficacy of SAR339658

Secondary Objective:

To assess the safety of SAR339658

Detailed Description

The study period per patient will include up to 4 weeks screening, 8 weeks treatment, 6 weeks post treatment safety follow-up, followed by a long term safety follow-up performed in the form of a phone interview at 3, 6, 12, 18 and 24 months from the last administration of the study medication.

After completion of the 8-week treatment phase, patients may be eligible to enter a long term safety study (LTS12593) for active treatment with SAR339658.

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
28
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
SAR339658SAR339658SAR339658 at Weeks 0, 2, 4, and 6
PlaceboPlaceboPlacebo at Weeks 0, 2, 4, and 6
Primary Outcome Measures
NameTimeMethod
Proportion of Participants with Clinical Response by Mayo ScoreAt Week 8
Secondary Outcome Measures
NameTimeMethod
Proportion of Participants with Clinical Remission by Mayo ScoreAt Week 8
Proportion of Participants with Mucosal HealingAt Week 8
Change from Baseline in Inflammatory Bowel Disease Questionnaire (IBDQ)At Weeks 4 and 8
Change from Baseline in Quality of Life (QoL) SF-36At Weeks 4 and 8
Change from Baseline in the partial Mayo ScoreAt Weeks 4 and 6
Number of Participants with adverse eventsUp to Week 17

Trial Locations

Locations (41)

Investigational Site Number 840071

🇺🇸

Rochester, New York, United States

Investigational Site Number 840065

🇺🇸

Sun City, Arizona, United States

Investigational Site Number 840059

🇺🇸

Mission Hills, California, United States

Investigational Site Number 840074

🇺🇸

San Diego, California, United States

Investigational Site Number 840061

🇺🇸

Littleton, Colorado, United States

Investigational Site Number 840008

🇺🇸

Miramar,, Florida, United States

Investigational Site Number 840048

🇺🇸

Winter Park,, Florida, United States

Investigational Site Number 840003

🇺🇸

Miami, Florida, United States

Investigational Site Number 840053

🇺🇸

Savannah,, Georgia, United States

Investigational Site Number 840001

🇺🇸

Chicago, Illinois, United States

Investigational Site Number 840005

🇺🇸

Oak Lawn, Illinois, United States

Investigational Site Number 840070

🇺🇸

Rochester Hills, Michigan, United States

Investigational Site Number 840078

🇺🇸

Hammond, Louisiana, United States

Investigational Site Number 840060

🇺🇸

Ocean Springs, Mississippi, United States

Investigational Site Number 840089

🇺🇸

Winston Salem, North Carolina, United States

Investigational Site Number 840024

🇺🇸

Mexico, Missouri, United States

Investigational Site Number 840051

🇺🇸

Great Neck, New York, United States

Investigational Site Number 840046

🇺🇸

Cincinnati, Ohio, United States

Investigational Site Number 840068

🇺🇸

Charlottesville,, Virginia, United States

Investigational Site Number 840038

🇺🇸

Sugar Land, Texas, United States

Investigational Site Number 840019

🇺🇸

Pasadena,, Texas, United States

Investigational Site Number 840088

🇺🇸

San Antonio, Texas, United States

Investigational Site Number 840064

🇺🇸

Wauwatosa, Wisconsin, United States

Investigational Site Number 124002

🇨🇦

Vancouver, Canada

Investigational Site Number 040003

🇦🇹

Innsbruck, Austria

Investigational Site Number 250003

🇫🇷

Grenoble, France

Investigational Site Number 250006

🇫🇷

Vandoeuvre Les Nancy, France

Investigational Site Number 276005

🇩🇪

Hamburg, Germany

Investigational Site Number 380003

🇮🇹

Firenze, Italy

Investigational Site Number 276001

🇩🇪

Berlin, Germany

Investigational Site Number 380006

🇮🇹

San Giovanni Rotondo, Italy

Investigational Site Number 276007

🇩🇪

Hamburg, Germany

Investigational Site Number 616002

🇵🇱

Lodz, Poland

Investigational Site Number 616001

🇵🇱

Gdynia, Poland

Investigational Site Number 616004

🇵🇱

Lodz, Poland

Investigational Site Number 616005

🇵🇱

Lodz, Poland

Investigational Site Number 616007

🇵🇱

Poznan, Poland

Investigational Site Number 616006

🇵🇱

Sroda Wielkopolska, Poland

Investigational Site Number 616008

🇵🇱

Warszawa, Poland

Investigational Site Number 840045

🇺🇸

Phoenixville, Pennsylvania, United States

Investigational Site Number 840034

🇺🇸

Seattle, Washington, United States

© Copyright 2025. All Rights Reserved by MedPath